Asset Management One’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.76M Buy
85,773
+3,411
+4% +$313K 0.02% 508
2025
Q4
$7.46M Buy
82,362
+1,039
+1% +$98.5K 0.02% 539
2025
Q3
$8.01M Sell
81,323
-1,816
-2% -$180K 0.02% 508
2025
Q2
$7.58M Sell
83,139
-409
-0.5% -$39.5K 0.02% 512
2025
Q1
$9.46M Buy
83,548
+1,635
+2% +$175K 0.03% 436
2024
Q4
$8.75M Buy
81,913
+602
+0.7% +$64.6K 0.03% 458
2024
Q3
$8.78M Buy
81,311
+3,251
+4% +$355K 0.03% 459
2024
Q2
$8.47M Sell
78,060
-2,409
-3% -$284K 0.03% 447
2024
Q1
$10.6M Sell
80,469
-8,251
-9% -$1.03M 0.04% 408
2023
Q4
$10.8M Buy
88,720
+487
+0.6% +$54.3K 0.04% 398
2023
Q3
$9.9M Sell
88,233
-8,769
-9% -$1.11M 0.04% 388
2023
Q2
$14.1M Buy
97,002
+34
+0% +$4.62K 0.06% 334
2023
Q1
$12.5M Sell
96,968
-11,291
-10% -$1.42M 0.06% 354
2022
Q4
$13.8M Sell
108,259
-5,065
-4% -$588K 0.07% 316
2022
Q3
$11.8M Sell
113,324
-1,122
-1% -$123K 0.06% 339
2022
Q2
$12M Buy
114,446
+6,441
+6% +$764K 0.06% 347
2022
Q1
$13.8M Sell
108,005
-3,443
-3% -$415K 0.05% 363
2021
Q4
$13.9M Buy
111,448
+1,115
+1% +$146K 0.05% 399
2021
Q3
$15.7M Sell
110,333
-4,665
-4% -$686K 0.06% 335
2021
Q2
$18M Sell
114,998
-1,712
-1% -$277K 0.07% 311
2021
Q1
$18.1M Sell
116,710
-3,838
-3% -$595K 0.07% 288
2020
Q4
$17.8M Sell
120,548
-450
-0.4% -$63.6K 0.07% 273
2020
Q3
$16M Sell
120,998
-4,248
-3% -$555K 0.07% 271
2020
Q2
$14.5M Buy
125,246
+7,729
+7% +$891K 0.07% 272
2020
Q1
$11.5M Sell
117,517
-1,117
-0.9% -$146K 0.07% 289
2019
Q4
$17.2M Sell
118,634
-200
-0.2% -$27.6K 0.08% 266
2019
Q3
$15.8M Buy
118,834
+2,495
+2% +$322K 0.08% 282
2019
Q2
$13.3M Buy
116,339
+9,112
+8% +$1.07M 0.07% 321
2019
Q1
$13.3M Sell
107,227
-237,362
-69% -$27M 0.07% 293
2018
Q4
$34.6M Buy
344,589
+2,493
+0.7% +$280K 0.08% 262
2018
Q3
$43.6M Sell
342,096
-216
-0.1% -$25.7K 0.09% 243
2018
Q2
$37M Buy
342,312
+10,478
+3% +$1.14M 0.08% 268
2018
Q1
$35.1M Buy
331,834
+4,014
+1% +$466K 0.08% 278
2017
Q4
$38.4M Sell
327,820
-786
-0.2% -$88.9K 0.08% 265
2017
Q3
$37.3M Buy
328,606
+8,893
+3% +$1.03M 0.09% 257
2017
Q2
$39.8M Sell
319,713
-12,516
-4% -$1.48M 0.1% 226
2017
Q1
$39.4M Sell
332,229
-36,096
-10% -$4.09M 0.1% 227
2016
Q4
$36.9M Buy
368,325
+338,677
+1,142% +$36.3M 0.09% 243
2016
Q3
$3.69M Sell
29,648
-19,121
-39% -$2.36M 0.05% 410
2016
Q2
$5.67M Sell
48,769
-14,949
-23% -$1.69M 0.09% 266
2016
Q1
$6.6M Sell
63,718
-48,410
-43% -$4.68M 0.1% 228
2015
Q4
$11.2M Sell
112,128
-5,821
-5% -$570K 0.17% 143
2015
Q3
$10.7M Sell
117,949
-29,523
-20% -$2.96M 0.16% 140
2015
Q2
$15.6M Sell
147,472
-19,025
-11% -$2.11M 0.22% 102
2015
Q1
$19.2M Sell
166,497
-19,659
-11% -$2.24M 0.24% 95
2014
Q4
$20.5M Buy
186,156
+35,829
+24% +$3.78M 0.27% 77
2014
Q3
$14.8M Buy
150,327
+103,154
+219% +$10.1M 0.2% 118
2014
Q2
$4.78M Buy
47,173
+25,461
+117% +$2.48M 0.07% 304
2014
Q1
$1.98M Buy
21,712
+815
+4% +$75.1K 0.03% 520
2013
Q4
$1.89M Sell
20,897
-107
-0.5% -$9.26K 0.03% 541
2013
Q3
$1.68M Sell
21,004
-7,402
-26% -$583K 0.03% 592
2013
Q2
$2.07M Buy
+28,406
New +$2.12M 0.03% 472

Other funds holding ZBH

Asset Management One's ZBH Position: Q1 2026 in Review

Asset Management One increased its Zimmer Biomet (ZBH) stake by 4.1% in Q1 2026, buying an estimated $313K and bringing the position to 85,773 shares worth $7.76M. The position accounts for 0.02% of the portfolio, ranked #508.

Asset Management One first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.6M in Q3 2018. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Asset Management One held 85,773 shares of Zimmer Biomet worth $7.76M as of Q1 2026.
  • Asset Management One bought 3,411 Zimmer Biomet shares in Q1 2026, an estimated $313K.
  • Zimmer Biomet made up 0.02% of Asset Management One's portfolio in Q1 2026, its #508 holding.
  • Asset Management One first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Asset Management One's Zimmer Biomet position peaked at $43.6M in Q3 2018.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.